A Genetic Validation Study Reveals a Role of Vitamin D Metabolism in the Response to Interferon-Alfa-Based Therapy of Chronic Hepatitis C
Figure 1
Treatment response according to CYP27B1-1260 rs10877012 genotype.
Overall sustained virologic response (SVR) rates across all HCV genotypes are shown for patients (A) with IL28B rs12979860 genotype CC and for (B) patients with IL28B rs12979860 genotype CT or TT. Numbers above bars indicate SVR rates in percent. Numbers below bars indicate absolute numbers of patients with SVR/all patients.